Evidence suggests that PON-1 and ARE activities are associated with the presence and extent of the disease in patients with stable CAD. 11, 12, 19 Akçay et al.   37  reported increased PON-1 activity in patients with metabolic syndrome compared with healthy controls. Here, PON1 is linked to metabolic syndrome.